Stellate Ganglion Block as Novel Treatment for Heart Failure Patients
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Phase 2/Phase 3
SUMMARY
Stellate Ganglion Block as Novel Treatment for Heart Failure Patients
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 70
Healthy Volunteers: f
View:
• Age 18 : 70 years old.
• NYHA Class III-IV Heart Failure.
• Heart failure with a reduced ejection fraction (HFrEF) LVEF ≤ 40% calculated using 2D echocardiography and Biplane Simpson's .
• Optimal tolerated Medical Therapy for Heart Failure.
Locations
Other Locations
Egypt
Assiut university
RECRUITING
Asyut
Assiut University
NOT_YET_RECRUITING
Asyut
Contact Information
Primary
Mina Fam, Resident
minassfam@yahoo.com
01122035368
Backup
Aly Tohamy, Lecturer
Ali.tohamy@gmail.com
Ali.tohamy@gmail.com
Time Frame
Start Date: 2024-02-05
Estimated Completion Date: 2025-01-01
Participants
Target number of participants: 108
Treatments
No_intervention: Narrow QRS complex Heart failure patients
Narrow QRS complex Heart failure patients with optimal medical treatment.
Active_comparator: : Narrow QRS complex Heart failure patients
: Narrow QRS complex Heart failure patients with optimal medical treatment with stellate ganglion block.
Active_comparator: Wide QRS complex heart failure patients
Wide QRS complex heart failure patients with optimal medical treatment who were non responders to CRT( retrospective and prospective) with stellate ganglion block.
Related Therapeutic Areas
Sponsors
Leads: Mina sobhi said fam